PAVmed Partners with Cancer Center to Advance Care
Company Announcements

PAVmed Partners with Cancer Center to Advance Care

PAVmed Inc (PAVM) just unveiled an announcement.

PAVmed Inc. has announced a new collaboration through its subsidiary, Veris Health Inc., with a leading Comprehensive Cancer Center to launch a pilot program using the Veris Cancer Care Platform. This initiative aims to enhance cancer patient care by enrolling participants in a cutting-edge monitoring program. The partnership marks a significant step for PAVmed in advancing cancer treatment and care.

Learn more about PAVM stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyLucid Diagnostics granted patent underlying its EsoGuard Esophageal DNA Ttest
TheFlyPAVmed subsidiary Veris Health awarded $1.8M NIH grant for cancer care
TheFlyPAVmed announces efforts to regain Nasdaq compliance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App